LUNGのROE（自己資本利益率）は？

Pulmonx CorpのROEは-122.76%です。

LUNGの配当利回りは？

Pulmonx Corpの配当利回りは0.00%です。

LUNGの品質スコア（Quality Score）は？

当社のAIはLUNGの総合財務品質を100点中23点と評価しています。収益性・成長性・負債・利益の安定性に基づく評価です。

LUNGは今が買い時ですか？

当社AIのタイミングスコアは100点中66点で、テクニカル指標とモメンタムから見た現在価格の相対的な魅力度を示します。

LUNGはどのセクターに属しますか？

Pulmonx CorpはHealthcare >> Medical Devicesセクターに分類されます（NASDAQ市場）

LUNG (NASDAQ) 株価分析 | PULMONX CORP

Stock Check Daily update data at 8:30 AM
(Price: 2026-07-31 | FS: 2026-06-30)

LUNG AI Analysis Summary

Our AI summary for LUNG: Pulmonx Corp (NASDAQ), Healthcare >> Medical Devices sector. The stock currently trades at a P/E of 0.00, ROE of -122.76%, a dividend yield of 0.00%. Its financial Quality Score stands at 23/100 — fundamentals below the market average. The AI Timing Score is 66/100 — technical signals are mixed; watch for a clearer trend. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.

LUNG

Pulmonx Corp

US:NASDAQ STOCK Healthcare >> Medical Devices News 94

USD 1.63

0.02 (1.24%) Day Change

Watchlist Portfolio Compare Chart

0.04

D/E

-122.8%

ROE

-41.9%

ROA

0.00%

Div Yield

Data partially updated

PULMONX CORP
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 1.63 Price 0.02 (1.24%) Day Change	NEWS SCORE: 94

LUNG, ファンダメンタルスコアはnot good ( ファンダメンタル = 23) そしてテクニカルスコアは ...(Sign In to See)...

Loading chart...

23 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: ROEが低い
ROAが低い
平均ROEが低い
昨年度のROEが一昨年比で低い
ROEが昨年度比で低い
ROAの伸びが低い
Last-year ROA is lower than last-2-years ROA.
NPMが低い
NPMの伸びが低い
NPMの伸びが低い

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Momentum indicators aligned on the daily timeframe

Unlock timing signals and detailed reasons

In details, quality factors are not good , financial health is not good , and ability to make profit is not quite good , ...

Deepscope 分析

45%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	94
Magic Formula Rank by ROA	N/A
Magic Formula Rank by ROE	N/A
Magic Formula Rank by ROIC	N/A
Price	1.63
PBV / Sector	1.73 / -101.57
Earning Per Share	-1.15

PE / Sector	N/A / 31.23
PEG or PE/Growth / Sector	N/A / 0.40
Average 1M Daily Value	0.79 M GREAT
Average 1W Daily Value	2.26 M GREAT

Timing Factors

85%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Financial Health

45%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

ポイントになる統計

54%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	-55.03 / 20.50
NPM Average (%) / Sector	-76.08 / -15.37
NPM Change Average (%) / Sector	-15.62 / 7.34
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	-41.94 / 39.11
ROA Average (%) / Sector	-36.60 / 5.58
ROA Change Average (%) / Sector	8.67 / 104.50
ROE (%) / Sector	-122.76 / -166.42
ROE Average (%) / Sector	-75.59 / -16.93
ROE Change Average (%) / Sector	34.27 / -500.08 GREAT
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

配当

Dividend (%) / Sector	N/A / 0.43
Dividend Average (%) / Sector	N/A / 1.85
Dividend Change Average (%) / Sector	N/A / 3.44

登録情報

Analyze Date	2026-08-01 08:00:08
Symbol	LUNG
Name	PULMONX CORP
Sector	Healthcare >> Medical Devices
Market	NASDAQ
Listed Shares	42.24 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	68.00 / 20,104.97

ニュース

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: 700 Chesapeake Drive, Redwood City, CA, United States, 94063

Phone: 650 364 0400

Website: https://pulmonx.com

Employees: 296

Sector: Healthcare >> Medical Devices

Description: Pulmonx Corporation, a commercial-stage medical technology company that provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease. It offers Zephyr Endobronchial Valve; and Chartis Pulmonary Assessment System, a balloon catheter and console system with flow and pressure sensors that are used to assess the presence of collateral ventilation. The company also offers LungTraX Platform, a cloud-based quantitative computed tomography analysis service that provides physicians with multiple products, such as LungTraX Connect to improve workup efficiency; LungTraX Detect to enable patient identification; and StratX Lung report that is designed for solution that includes information on emphysema destruction, fissure completeness, and lobar volume to help identify target lobes for treatment with Zephyr Valves. It serves emphysema patients in the United States, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company was formerly known as Pulmonx and changed its name to Pulmonx Corporation in December 2013. Pulmonx Corporation was incorporated in 1995 and is headquartered in Redwood City, California.